Robin Mukherjee

2.9k total citations · 1 hit paper
16 papers, 2.1k citations indexed

About

Robin Mukherjee is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robin Mukherjee has authored 16 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robin Mukherjee's work include Hormonal Regulation and Hypertension (7 papers), Heart Failure Treatment and Management (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Robin Mukherjee is often cited by papers focused on Hormonal Regulation and Hypertension (7 papers), Heart Failure Treatment and Management (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Robin Mukherjee collaborates with scholars based in United States, Australia and Netherlands. Robin Mukherjee's co-authors include Harvey D. White, Eugene Braunwald, Keith A.A. Fox, Michael A. Blazing, Eldrin F. Lewis, Karen E. Ramsey, Jean‐Lucien Rouleau, Joanne Palmisano, James A. de Lemos and David W. Bilheimer and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Robin Mukherjee

16 papers receiving 2.0k citations

Hit Papers

Early Intensive vs a Delayed Conservative Simvastatin Str... 2004 2026 2011 2018 2004 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
    2004 971 citations James A. de Lemos, Michael A. Blazing et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Mukherjee United States 11 1.2k 1.0k 879 346 314 16 2.1k
Estella Kanevsky United States 10 659 0.6× 1.8k 1.7× 554 0.6× 472 1.4× 224 0.7× 15 2.1k
Na‐Qiong Wu China 31 1.2k 1.0× 1.9k 1.8× 1.1k 1.2× 193 0.6× 236 0.8× 192 3.3k
Armando Lira Pineda United States 13 800 0.7× 2.3k 2.2× 731 0.8× 594 1.7× 245 0.8× 21 2.8k
Jordan Fulcher Australia 10 648 0.5× 1.0k 1.0× 421 0.5× 379 1.1× 156 0.5× 18 1.7k
Anho Liem Netherlands 24 829 0.7× 1.4k 1.3× 702 0.8× 320 0.9× 97 0.3× 53 2.3k
Philippe Brudi United States 20 1.2k 1.0× 1.4k 1.3× 533 0.6× 552 1.6× 320 1.0× 71 2.3k
Mary Jane Geiger United States 20 552 0.5× 748 0.7× 542 0.6× 246 0.7× 107 0.3× 31 2.5k
L. Toivanen Finland 4 546 0.5× 1.1k 1.0× 764 0.9× 262 0.8× 104 0.3× 4 1.9k
Hardi Mundl United States 13 687 0.6× 1.2k 1.2× 958 1.1× 122 0.4× 220 0.7× 30 2.1k
Kimmo Kohtamäki Finland 7 511 0.4× 1.2k 1.1× 637 0.7× 262 0.8× 92 0.3× 9 1.9k

Countries citing papers authored by Robin Mukherjee

Since Specialization
Citations

This map shows the geographic impact of Robin Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Mukherjee more than expected).

Fields of papers citing papers by Robin Mukherjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Mukherjee. The network helps show where Robin Mukherjee may publish in the future.

Co-authorship network of co-authors of Robin Mukherjee

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Mukherjee. A scholar is included among the top collaborators of Robin Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Mukherjee. Robin Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Qin, Lei, Laura Horne, Akhtar Ashfaq, et al.. (2017). SP321HEALTH CARE RESOURCE UTILIZATION FOLLOWING HYPERKALEMIA IN ADULTS IN THE UK. Nephrology Dialysis Transplantation. 32(suppl_3). iii216–iii216. 1 indexed citations
2.
Horne, Laura, Akhtar Ashfaq, Sharon MacLachlan, et al.. (2017). MP380CLINICAL OUTCOMES ASSOCIATED WITH HYPERKALEMIA IN ADULTS IN THE UK. Nephrology Dialysis Transplantation. 32(suppl_3). iii567–iii567. 1 indexed citations
3.
4.
Siegelaar, Sarah E., Willem Kulik, Henk van Lenthe, et al.. (2009). A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress. Diabetes Obesity and Metabolism. 11(7). 709–714. 17 indexed citations
5.
Gheorghiade, Mihai, Sadiya S. Khan, John E. Blair, et al.. (2009). The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. American Heart Journal. 158(3). 437–443. 11 indexed citations
6.
Pitt, Bertram, George L. Bakris, Luís M. Ruilope, Lorenzo A. DiCarlo, & Robin Mukherjee. (2008). Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 118(16). 1643–1650. 184 indexed citations
7.
Pitt, Bertram, Mihai Gheorghiade, Faı̈ez Zannad, et al.. (2006). Evaluation of Eplerenone in the Subgroup of EPHESUS Patients with Baseline Left Ventricular Ejection Fraction ≤30%. European Journal of Heart Failure. 8(3). 295–301. 34 indexed citations
8.
Epstein, Murray, Gordon H. Williams, Myron H. Weinberger, et al.. (2006). Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes. Clinical Journal of the American Society of Nephrology. 1(5). 940–951. 353 indexed citations
9.
Pitt, Bertram, Harvey D. White, José Carlos Nicolau, et al.. (2005). Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure. Journal of the American College of Cardiology. 46(3). 425–431. 266 indexed citations
10.
Veldhuisen, Dirk J. van, Michael Aschermann, Faı̈ez Zannad, et al.. (2005). 353 Eplerenone benefit at 30 days in high-risk subgroups in the EPHESUS trial. European Journal of Heart Failure Supplements. 4(1). 79–79. 2 indexed citations
11.
Salerno, Christina M., Laura A. Demopoulos, Robin Mukherjee, & Alan H. Gradman. (2004). Combination Angiotensin Receptor Blocker/Hydrochlorothiazide as Initial Therapy in the Treatment of Patients With Severe Hypertension. Journal of Clinical Hypertension. 6(11). 614–620. 33 indexed citations
12.
Lemos, James A. de, Michael A. Blazing, Stephen D. Wiviott, et al.. (2004). Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes. JAMA. 292(11). 1307–1307. 971 indexed citations breakdown →
13.
14.
Bussel, James B., Robin Mukherjee, & Anne J. Stone. (2001). A pilot study of rhuIL-11 treatment of refractory ITP. American Journal of Hematology. 66(3). 172–177. 36 indexed citations
15.
Bussel, James B., Robin Mukherjee, & Anne J. Stone. (2001). A pilot study of rhuIL‐11 treatment of refractory ITP. American Journal of Hematology. 66(3). 172–177. 1 indexed citations
16.
Spinale, F. G., Ward V. Houck, Scott B. Kribbs, et al.. (1998). Growth hormone supplementation with developing congestive heart failure Effects on left ventricular cellular structure and composition. 180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Estella Kanevsky Breakdown of academic impact, for papers by Na‐Qiong Wu Breakdown of academic impact, for papers by Armando Lira Pineda Breakdown of academic impact, for papers by Jordan Fulcher Breakdown of academic impact, for papers by Anho Liem Breakdown of academic impact, for papers by Philippe Brudi Breakdown of academic impact, for papers by Mary Jane Geiger Breakdown of academic impact, for papers by L. Toivanen Breakdown of academic impact, for papers by Hardi Mundl Breakdown of academic impact, for papers by Kimmo Kohtamäki
Rankless by CCL
2026